Publication | Closed Access

Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant

VaccinationViral ReplicationSynthetic VirologyRecombinant Dense BodiesViral PathogenesisImmunologyAntiviral ResponseVirologyVaccine DesignHuman CytomegalovirusImmunotherapyMedicine